Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9555494 | 0.94 | AGTR1 (0.58) | — | |
| SCHEMBL9534309 | 0.92 | BRS3 (0.48) | — | |
| SCHEMBL9555325 | 0.91 | PPARG (0.58) | PPARG | |
| SCHEMBL9536546 | 0.90 | AGTR1 (0.53) | PPARG | |
| SCHEMBL9536354 | 0.90 | PPARG (0.53) | PPARG | |
| SCHEMBL9530143 | 0.90 | PPARG (0.53) | PPARG | |
| SCHEMBL9555337 | 0.90 | PPARG (0.57) | PPARG | |
| SCHEMBL9554307 | 0.89 | PPARG (0.52) | PPARG | |
| SCHEMBL9038523 | 0.89 | AGTR1 (0.57) | PPARG | |
| SCHEMBL9530067 | 0.88 | PPARG (0.52) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5238952-A | Treating glaucoma disorders | G. D. SEARLE & CO. (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0555331-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. | SEARLE & CO (US) | 1993-08-18 | — | — | EP | disclosed |
| WO-1992007834-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |
| US-5087634-A | N-substituted imidazol-2-one compounds for treatment of circulatory disorders | G. D. SEARLE & CO. (US) | 1992-02-11 | — | — | US | disclosed |